"Chemokine CCL11" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine that is specific for CCR3 RECEPTORS. It is a potent chemoattractant for EOSINOPHILS.
| Descriptor ID |
D054413
|
| MeSH Number(s) |
D12.644.276.374.200.110.550 D12.776.467.374.200.110.550 D23.125.300.110.550 D23.469.200.110.550 D23.529.374.200.110.550
|
| Concept/Terms |
Chemokine CCL11- Chemokine CCL11
- CCL11, Chemokine
- Small Chemokine (C-C Motif) Ligand 11
- Eotaxin-1
- Eotaxin 1
- CCL11 Chemokine
- Chemokine, CCL11
- Chemokine (C-C Motif) Ligand 11
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL11".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL11".
This graph shows the total number of publications written about "Chemokine CCL11" by people in this website by year, and whether "Chemokine CCL11" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL11" by people in Profiles.
-
Syed BA, Kumar S, Bielory L. Current options and emerging therapies for anterior ocular inflammatory disease. Curr Opin Allergy Clin Immunol. 2014 Oct; 14(5):485-9.
-
Crosby JR, Guha M, Tung D, Miller DA, Bender B, Condon TP, York-DeFalco C, Geary RS, Monia BP, Karras JG, Gregory SA. Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice. J Pharmacol Exp Ther. 2007 Jun; 321(3):938-46.
-
Keslacy S, Tliba O, Baidouri H, Amrani Y. Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity. Mol Pharmacol. 2007 Feb; 71(2):609-18.